Work

Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

Year: 2014

Type: article

Study design: Observational Study

Source: European Journal of Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s00259-014-2753-3

Authors: the Alzheimer’s Disease Neuroimaging Initiative, S. M. Landau, B. A. Thomas, L. Thurfjell, M. Schmidt, R. Margolin, M. Mintun, M. Pontecorvo, S. L. Baker, W. J. Jagust

Institutions: Lawrence Berkeley National Laboratory, University of California, Berkeley, University College London, Janssen (Belgium), Avid Radiopharmaceuticals (United States), Janssen Alzheimer Immunotherapy Research & Development (United States)

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, University College London Hospitals NHS Foundation Trust, National Institutes of Health, Avid Radiopharmaceuticals, National Institute on Aging

Awards: G104586243, UC Davis Alzheimer's Disease Core Center, G1557667123, G2795071984, G4894255983

OpenAlex ID: W2010695389

FWCI: 16.85

Cites: 21

Cited by: 294

Related to: 10